|
|
Volumn 29, Issue 2, 2012, Pages 1253-1254
|
|
Second-line chemotherapy with docetaxel and carboplatin in paclitaxel and platinum-pretreated ovarian, fallopian tube, and peritoneal cancer
a
|
|
Author keywords
Carboplatin; Chemotherapy; Docetaxel; Early progression; Recurrent ovarian cancer
|
|
Indexed keywords
CARBOPLATIN;
DOCETAXEL;
PACLITAXEL;
PLATINUM;
ANTINEOPLASTIC AGENT;
TAXOID;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER RESISTANCE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
NEUROPATHY;
NEUTROPENIA;
OVARY CANCER;
OVERALL SURVIVAL;
PERITONEUM CANCER;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RECURRENT CANCER;
RETROSPECTIVE STUDY;
SURVIVAL TIME;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UTERINE TUBE TUMOR;
DRUG EFFECT;
DRUG RESISTANCE;
FOLLOW UP;
LETTER;
OVARY TUMOR;
PERITONEUM TUMOR;
SALVAGE THERAPY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
DRUG RESISTANCE, NEOPLASM;
FALLOPIAN TUBE NEOPLASMS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
PERITONEAL NEOPLASMS;
PLATINUM;
RETROSPECTIVE STUDIES;
SALVAGE THERAPY;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 84866268035
PISSN: 13570560
EISSN: 1559131X
Source Type: Journal
DOI: 10.1007/s12032-011-9878-z Document Type: Article |
|
Times cited : (5)
|
|
References (5)
|
